An amphiphilic dendrimer as a light-activable immunological adjuvant for in situ cancer vaccination
Immunological adjuvants are a crucial component of cancer vaccines. Here the authors design a light-activable immunological adjuvant, based on hypoxia-responsive amphiphilic dendrimer nanoparticles loaded with a photodynamic agent, promoting anti-tumor immune responses in preclinical cancer models.
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/9406f8b05e734a97845b344a34803f0b |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|